Outcome-Based Pricing: Cure for An Ailing Healthcare Industry?

The buzz: “One in four health plans now have ‘at least one outcomes-based contract’ with a drug maker, an Avalere Health survey showed.” (Bruce Jaspen) A distorted reimbursement model has pushed soaring healthcare costs to the top of government budgets around the globe. What to do? Life sciences industry players are experimenting with innovative outcome-based pricing models that align reimbursements with positive outcomes, while improving pricing stability and predictability in the life sciences industry. We will explain this model and discuss alternatives for all stakeholders in the value chain. The experts speak. Joe Miles, SAP: “It is health that is real wealth and not pieces of gold and silver” (Gandhi). Bob Steller, Vistex: “However beautiful the strategy, you should occasionally look at the results” (Churchill). Joseph M. Coppola, Deloitte: “When the music changes, so does the dance” (African Proverb). Join us for Outcome-Based Pricing: Cure for An Ailing Healthcare Industry,